The burden of chronic diseases has only been
increasing since past few years. The cases for cancer, for example, are growing
rapidly. According to the American Cancer Society, from 2016–2019, the number
of new cases of cancer in the U.S. increased from 1,685,210 to 1,762,450, and
the cancer mortality rose from 595,690 to 606,880 during the same time period.
Doubtless, a number of advancements have been made in the medical industry for
developing a proper cure for cancer and other rare chronic diseases, however,
the fact remains that there is a long way to go before anything certain comes
to light.
To Learn More About this report: https://bit.ly/3doafIc |
In 2019, North America was the largest gene therapy market, which is ascribed to the rising number of cancer and rare disease cases and the presence of a large number of key companies in the region. In addition to this, various gene therapy products are getting regulatory approvals in North America. Other than this, the adoption of gene therapy is also projected to rise substantially in the Asia-Pacific because of the cost-effective labor and rising activities of major industry players.
Report Coverage
·
Provides
comprehensive understanding of the market with the help of informed market outlook,
opportunities, challenges, trends, size and growth, competitive analysis, major
competitors and Porter analysis
·
Porter analysis
identifies competitive forces within the market
·
Provides
information on the historical and current market size and the future potential
of the market
·
Provides sizes
of key regional markets using yardsticks of segments